Literature DB >> 27516967

Co-infection of dengue fever and hepatitis A in a Russian traveler.

Elena Volchkova1, Karina Umbetova1, Olga Belaia1, Maria Sviridova1, Ludmila Dmitrieva1, Daria Arutyunova1, Dmitriy Chernishov2, Ludmila Karan3.   

Abstract

We report a hepatitis A (HAV) and dengue virus (DENV) co-infection in Russian man who had been traveling to Dominican Republic. At admission to the hospital hemorrhagic and jaundice symptoms were observed in patient. PCR tests of blood serum and urine revealed RNA dengue virus type 3, HAV RNA, anti-HAV-IgM.

Entities:  

Keywords:  Dengue virus; Viral hepatitis A

Year:  2016        PMID: 27516967      PMCID: PMC4976605          DOI: 10.1016/j.idcr.2016.07.002

Source DB:  PubMed          Journal:  IDCases        ISSN: 2214-2509


In the last 30–40 years, incidence of dengue hemorrhagic fever (DHF) has increased in the Americas and the Caribbean region resulting in greater prevalence of this disease among travelers [1], [2]. In several studies, dengue virus infection was documented in 7% to 45% of all returning febrile travelers [3], [4]. It should be noted, that in the Caribbean Sea basin hepatitis A is widespread. Therefore high likelihood of co-infection is possible, which manifests itself by polymorphism of clinical appearance making diagnosis difficult and worsening prognosis.

Case report

A 47-year-old patient was admitted to an intensive therapy department of infection hospital in Moscow with acute viral hepatitis A on the 16th day of the illness. He complained of weakness and abdominal discomfort. 30 days before the onset of the disease, the patient had returned from a 15-day trip to Dominican Republic. He had fallen ill acutely with a rising of temperature to 38∘C, pain in large joints, loss of appetite and nausea. On the 4th day of the disease urine became dark and sclerae turned yellow. On the 6th day of the disease the patient was admitted to the district hospital. Four days later patient's condition worsened, euphoria and excitability were noted. Therefore he was transferred to the intensive care unit (ICU). During tests HAV-IgM was detected by ELISA method and the patient was then transferred to the Infectious Diseases hospital. On admission, his was s conscious not clearly aware of his condition, euphoric and talkative, but questions were not always answered appropriately. Meningeal and focal neurological symptoms were not observed. Fever was absent. He had marked hemorrhagic and jaundice symptoms. Abdominal and chest examinations were unremarkable. Laboratory-test results are shown in Table 1. The severity of the patient's condition was due to a combination of renal and hepatic insufficiency, with disseminated intravascular coagulation. Considering the marked renal failure and hemorrhagic manifestations, the diagnoses of hemorrhagic fever with renal syndrome (HFRS) and leptospirosis were considered. The AST and ALT peak were not high because patient was hospitalized later on 16th day of the disease. Antibodies to the virus HFRS hantavirus in reaction indirect immunofluorescence were not detected and microagglutination assay for leptospirosis was negative.
Table 1

Relevant Test Results.

In ICUIn infection department
Hgb (g/dL)8.37.8
WBC (per mm3)21,2006700
RBC (per mm3)28102570
PLT (per mm3)225,000342,000
Band neutrophils (%)117
Mature neutrophils (%)7865
Albumin (g/dL)2.84.5
Total bilirubin (mg/dL)9.20.76
Creatinine (mg/dL)129288.3
Serum urea (mg/dL)3.30.49
ALT8088
AST3386
Protrombin Index (%)6483
INR1.561.2
During treatment, the patient received antibacterial therapy (ceftriaxon 4 g/day and levofloxacinum 1 g/day), disintoxication therapy (electrolytes and colloid solutions) and diuretic therapy. Because of renal failure, continuous venovenous hemofiltration was carried out. On 19th day of illness, he was given intravenous gamma globulin 40 g. Periodically, body temperature increased up to 38.3∘C that was reduced after administration of nonsteroidal anti-inflammatory drugs. Taking into consideration the dynamics of the disease, the clinical picture with the accession of hemorrhagic rash, renal failure and the background of a countrywide Dengue epidemic examination for Dengue fever, hemorrhagic form was assigned. At that point, the diagnosis of dengue hemorrhagic fever was considered and a serum dengue virus PCR was positive. Zika virus and malaria assays by PCR were negative. On the 26 th day of illness, he began to improve and was discharged soon after that to be followed in Infection Disease department N5 in Infectious Disease clinic.

Discussion

This is the first description of the HAV with DENV coinfection in Russian citizen with the development of acute renal failure, imported from the Dominican Republic. Severe course of HAV with DENV coinfection with the development of acute liver failure was described by doctors from India [5]. The presented case history is exclusive currently, but the broadening of the tourist flow to the Caribbean region could increase the frequency of occurrence of such cases. A stay in Dominican Republic may be accompanied by simultaneous infections by various infectious agents, therefore it is necessary to carry out complex screening tests for a variety of endemic agents of a given territory in proper time in order to carry out early and adequate therapy.

Conflicts of interest

None of the authors have any conflicts of interest to declare.
  4 in total

1.  Acute Liver Failure Caused by Hepatitis A Virus with Dengue Coinfection.

Authors:  Sunil Taneja; Amritangsu Borakokty; Ajay Duseja; Radha Krishan Dhiman; Yogesh Chawla
Journal:  J Clin Exp Hepatol       Date:  2016-02-01

2.  Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop.

Authors:  T Jelinek; N Mühlberger; G Harms; M Corachán; M P Grobusch; J Knobloch; U Bronner; H Laferl; A Kapaun; Z Bisoffi; J Clerinx; S Puente; G Fry; M Schulze; U Hellgren; I Gjørup; P Chalupa; C Hatz; A Matteelli; M Schmid; L N Nielsen; S da Cunha; J Atouguia; B Myrvang; K Fleischer
Journal:  Clin Infect Dis       Date:  2002-10-10       Impact factor: 9.079

3.  Severe dengue virus infection in travelers: risk factors and laboratory indicators.

Authors:  Ole Wichmann; Joaquim Gascon; Mirjam Schunk; Sabino Puente; Heli Siikamaki; Ida Gjørup; Rogelio Lopez-Velez; Joannes Clerinx; Gabriele Peyerl-Hoffmann; Anders Sundøy; Blaise Genton; Peter Kern; Guido Calleri; Miguel de Górgolas; Nikolai Mühlberger; Tomas Jelinek
Journal:  J Infect Dis       Date:  2007-03-02       Impact factor: 5.226

4.  Spectrum of disease and relation to place of exposure among ill returned travelers.

Authors:  David O Freedman; Leisa H Weld; Phyllis E Kozarsky; Tamara Fisk; Rachel Robins; Frank von Sonnenburg; Jay S Keystone; Prativa Pandey; Martin S Cetron
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

  4 in total
  1 in total

1.  Viral characteristics and clinical presentation in dengue co-infection- Findings from a facility based observational study in Odisha, India.

Authors:  Jyotirmayee Turuk; Subrata K Palo; Sonalika Rath; Subhra Subhadra; Jyotsnamayee Sabat; Prakash K Sahoo; Sailendra Panda; Sanghamitra Pati
Journal:  J Family Med Prim Care       Date:  2021-08-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.